1. Home
  2. NTRA vs CHD Comparison

NTRA vs CHD Comparison

Compare NTRA & CHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo Church & Dwight Company Inc.

CHD

Church & Dwight Company Inc.

HOLD

Current Price

$84.61

Market Cap

21.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
CHD
Founded
2003
1846
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
21.6B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
CHD
Price
$244.06
$84.61
Analyst Decision
Strong Buy
Buy
Analyst Count
16
14
Target Price
$227.69
$101.43
AVG Volume (30 Days)
1.7M
2.4M
Earning Date
11-06-2025
10-31-2025
Dividend Yield
N/A
1.40%
EPS Growth
N/A
42.14
EPS
N/A
3.17
Revenue
$2,116,676,000.00
$6,141,000,000.00
Revenue This Year
$32.77
$2.52
Revenue Next Year
$16.51
$4.02
P/E Ratio
N/A
$26.67
Revenue Growth
38.17
1.45
52 Week Low
$125.38
$81.33
52 Week High
$245.59
$116.46

Technical Indicators

Market Signals
Indicator
NTRA
CHD
Relative Strength Index (RSI) 80.03 48.56
Support Level $233.67 $83.37
Resistance Level $240.18 $84.86
Average True Range (ATR) 7.39 1.35
MACD 0.68 0.18
Stochastic Oscillator 97.49 80.51

Price Performance

Historical Comparison
NTRA
CHD

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About CHD Church & Dwight Company Inc.

Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which together with Arm & Hammer constitute around 70% of its annual sales and profits. Most recently, the firm added Touchland and its hand sanitizer business to its fold. Even as it works to expand its product reach, Church & Dwight still derives around 80% of its sales from its home market in the US.

Share on Social Networks: